{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:03:29Z","timestamp":1781665409008,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771812"],"award-info":[{"award-number":["81771812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571637"],"award-info":[{"award-number":["81571637"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271532"],"award-info":[{"award-number":["81271532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for the Central Universities of China","award":["2012017yjsy190"],"award-info":[{"award-number":["2012017yjsy190"]}]}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejrad.2018.05.014","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T12:51:59Z","timestamp":1526561519000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["The prognostic value of SUVmax measuring on primary lesion and ALN by 18F-FDG PET or PET\/CT in patients with breast cancer"],"prefix":"10.1016","volume":"105","author":[{"given":"Wei","family":"Diao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.ejrad.2018.05.014_bib0010","first-page":"1561","article-title":"Local recurrence after mastectomy or breast-conserving surgery and radiation","volume":"14","author":"Freedman","year":"2000","journal-title":"Oncology (Williston Park)"},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-015-0522-9","article-title":"Associations between the standardized uptake value of 18F-FDG PET\/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma","volume":"13","author":"Jung","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2018.05.014_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1102\/1470-7330.2008.0010","article-title":"Predictive and prognostic value of FDG-PET","volume":"8","author":"Geus-Oei","year":"2008","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.ejrad.2018.05.014_bib0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11604-015-0516-0","article-title":"Present and future role of FDG-PET\/CT imaging in the management of breast cancer","volume":"34","author":"Kitajima","year":"2016","journal-title":"Jpn. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/RLU.0000000000001049","article-title":"Prognostic implications of the SUVmax of primary tumors and metastatic lymph node measured by 18F-FDG PET in patients with uterine cervical cancer: a meta-analysis","volume":"41","author":"Sarker","year":"2016","journal-title":"Clin. Nucl. Med."},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0035","article-title":"Prognostic value of 18F-FDG PET\/CT in surgical non-small cell lung cancer: a meta-analysis","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12032-014-0446-1","article-title":"Predictive value of F-18 FDG PET\/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants","volume":"32","author":"Xie","year":"2015","journal-title":"Med. Oncol."},{"issue":"10","key":"10.1016\/j.ejrad.2018.05.014_bib0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","article-title":"FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters","volume":"29","author":"Buck","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.ejrad.2018.05.014_bib0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-013-2687-7","article-title":"Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography\/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study","volume":"141","author":"Kadoya","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.ejrad.2018.05.014_bib0055","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1177\/0284185114556929","article-title":"Preoperative 18F-FDG PET\/CT predicts disease-free survival in patients with primary invasive ductal breast cancer","volume":"56","author":"Jo","year":"2015","journal-title":"Acta Radiol."},{"issue":"22","key":"10.1016\/j.ejrad.2018.05.014_bib0060","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/cncr.29565","article-title":"Risk stratification in patients with advanced-stage breast cancer by pretreatment [18F]FDG PET\/CT","volume":"121","author":"Chen","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.breast.2012.05.009","article-title":"Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?","volume":"22","author":"De Cicco","year":"2013","journal-title":"Breast"},{"issue":"9","key":"10.1016\/j.ejrad.2018.05.014_bib0070","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/MEG.0b013e328323d6fa","article-title":"Prognostic significance of SUV on PET\/CT in patients with esophageal cancer: a systematic review and meta-analysis","volume":"21","author":"Pan","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"Berghmans","year":"2008","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2018.05.014_bib0080","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2967\/jnumed.113.133801","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis","volume":"55","author":"Pak","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.ejrad.2018.05.014_bib0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00259-014-2903-7","article-title":"Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis","volume":"42","author":"Im","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"24","key":"10.1016\/j.ejrad.2018.05.014_bib0090","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat. Med."},{"issue":"7414","key":"10.1016\/j.ejrad.2018.05.014_bib0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.ejrad.2018.05.014_bib0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s13058-014-0502-y","article-title":"Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden","volume":"16","author":"Ahn","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.ejrad.2018.05.014_bib0105","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4143\/crt.2015.172","article-title":"18F-FDG\/PET May help to identify a subgroup of patients with T1-T2 breast cancer and 1-3 positive lymph nodes who are at a high risk of recurrence after mastectomy","volume":"48","author":"Chang","year":"2016","journal-title":"Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.ejrad.2018.05.014_bib0110","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s00259-015-3102-x","article-title":"Basal 18F-fluoro-2-deoxy-d-glucose positron emission tomography\/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer","volume":"42","author":"Garcia Vicente","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2018.05.014_bib0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.breast.2016.08.003","article-title":"Prognostic significance of preoperative 18F-FDG PET\/CT for breast cancer subtypes","volume":"30","author":"Higuchi","year":"2016","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13139-014-0296-y","article-title":"Correlation of primary tumor FDG uptake with clinicopathologic prognostic factors in invasive ductal carcinoma of the breast","volume":"49","author":"Jo","year":"2015","journal-title":"Nucl. Med. Mol. Imaging"},{"issue":"9","key":"10.1016\/j.ejrad.2018.05.014_bib0125","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2967\/jnumed.111.098640","article-title":"18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET\/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer","volume":"53","author":"Song","year":"2012","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2018.05.014_bib0130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s13139-012-0161-9","article-title":"Prognostic significance of metabolic tumor volume measured by 18F-FDG PET\/CT in operable primary breast cancer","volume":"46","author":"Kim","year":"2012","journal-title":"Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.ejrad.2018.05.014_bib0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4048\/jbc.2015.18.2.173","article-title":"Axillary lymph node-to-primary tumor standard uptake value ratio on preoperative 18F-FDG PET\/CT: a prognostic factor for invasive ductal breast cancer","volume":"18","author":"Kim","year":"2015","journal-title":"J. Breast Cancer"},{"issue":"11","key":"10.1016\/j.ejrad.2018.05.014_bib0140","first-page":"1787","article-title":"Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET\/CT in operable triple-negative","volume":"44","author":"Kim","year":"2017","journal-title":"Breast Cancer"},{"issue":"46","key":"10.1016\/j.ejrad.2018.05.014_bib0145","article-title":"CONSORT-independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer","volume":"96","author":"Jung","year":"2017","journal-title":"Med. (Baltim.)"},{"issue":"4","key":"10.1016\/j.ejrad.2018.05.014_bib0150","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/cam4.1394","article-title":"A hierarchical prognostic model for risk stratification in patients with early breast cancer according to 18F-fludeoxyglucose uptake and clinicopathological parameters","volume":"7","author":"Cha","year":"2018","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12149-017-1217-9","article-title":"Prognostic value of FDG-PET and DWI in breast cancer","volume":"32","author":"Kitajima","year":"2018","journal-title":"Ann. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2018.05.014_bib0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2967\/jnumed.107.047787","article-title":"Recommendations on the use of 18F-FDG PET in oncology","volume":"49","author":"Fletcher","year":"2008","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.ejrad.2018.05.014_bib0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3413\/Nukmed-0566-13-03","article-title":"Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma","volume":"53","author":"Pak","year":"2014","journal-title":"Nuklearmedizin"},{"issue":"26","key":"10.1016\/j.ejrad.2018.05.014_bib0170","doi-asserted-by":"crossref","first-page":"e1037","DOI":"10.1097\/MD.0000000000001037","article-title":"Preoperative standardized uptake value of metastatic lymph nodes measured by 18F-FDG PET\/CT improves the prediction of prognosis in gastric cancer","volume":"94","author":"Song","year":"2015","journal-title":"Med. (Baltim.)"},{"issue":"3","key":"10.1016\/j.ejrad.2018.05.014_bib0175","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ygyno.2014.01.039","article-title":"Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis","volume":"132","author":"Ghooshkhanei","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ejrad.2018.05.014_bib0180","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00330-015-4132-2","article-title":"The role of 18F-FDG PET\/CT on staging and prognosis in patients with small cell lung cancer","volume":"26","author":"Zer","year":"2016","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2018.05.014_bib0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tips.2016.10.001","article-title":"Introducing the microbiome into precision medicine","volume":"38","author":"Kuntz","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.ejrad.2018.05.014_bib0190","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.semnuclmed.2016.07.006","article-title":"PSMA PET and radionuclide therapy in prostate cancer","volume":"46","author":"Bouchelouche","year":"2016","journal-title":"Semin. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2018.05.014_bib0195","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4048\/jbc.2011.14.3.204","article-title":"The prognostic significance of the lymph node ratio in axillary lymph node positive breast cancer","volume":"78","author":"Kim","year":"2011","journal-title":"J. Breast Cancer"},{"issue":"7","key":"10.1016\/j.ejrad.2018.05.014_bib0200","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IGC.0b013e31829ee012","article-title":"Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography or PET-computed tomography in cervical cancer: a meta-analysis","volume":"23","author":"Zhao","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"11","key":"10.1016\/j.ejrad.2018.05.014_bib0205","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"Li","year":"2003","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.ejrad.2018.05.014_bib0210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4048\/jbc.2011.14.3.204","article-title":"The prognostic significance of the lymph node ratio in axillary lymph node positive breast cancer","volume":"14","author":"Kim","year":"2011","journal-title":"J. Breast Cancer"},{"issue":"2","key":"10.1016\/j.ejrad.2018.05.014_bib0215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/02841860701678761","article-title":"Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer","volume":"47","author":"Lale Atahan","year":"2008","journal-title":"Acta Oncol."},{"issue":"12","key":"10.1016\/j.ejrad.2018.05.014_bib0220","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1245\/s10434-015-4526-z","article-title":"Correlation between F-18 fluorodeoxyglucose positron emission tomography metabolic parameters and dynamic contrast-enhanced MRI-derived perfusion data in patients with invasive ductal breast carcinoma","volume":"22","author":"Kim","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.ejrad.2018.05.014_bib0225","article-title":"Intrareader reliability of FDG PET\/CT primary tumor metabolic volume and total glycolytic activity","volume":"198","author":"Shah","year":"2012","journal-title":"AJR"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X18301773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X18301773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T08:41:40Z","timestamp":1569228100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X18301773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":45,"alternative-id":["S0720048X18301773"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2018.05.014","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of SUVmax measuring on primary lesion and ALN by 18F-FDG PET or PET\/CT in patients with breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2018.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}